Prevention and treatment of dermal toxicity in children receiving anti-tumor radiation

Radiation therapy, being an integral part of malignant neoplasms treatment in children, is unfortunately inevitably accompanied by a high frequency of adverse dermatological reactions. Development of radiodermatitis — from erythema and dryness to oozing lesion, painfulness and ulcerations — is a considerable clinical problem, significantly deteriorates the quality of life of young patients and creates the risk of infectious complications, that could potentially lead to interruptions in life-saving treatment. Critically important is that currently there are almost no randomized controlled studies in the pediatric population specifically devoted to systematic assessment of profile, severity and optimal management of dermatological toxicity caused by radiation therapy. This article focuses on the urgent need and crucial significance of comprehensive supportive skin therapy during and after radiation. Such care includes regular and targeted use of special dermatoprotective products. Moisturizing creams and ointments are designed to combat dryness, desquamation and maintain the integrity of the hydrolipid barrier. Barrier agents (often based on zinc, silicone or special polymers) create a protective film that minimizes friction, mechanical damage and contact with irritants as well as promote healing. The main objectives of this strategy are effective management of clinical manifestations of acute radiodermatitis, maximum possible prevention and minimization of severe skin lesions, as well as significant acceleration of their recovery and re-epithelization processes in the post-radiation period. The obtained results and collated recommendations are of significant practical interest to a wide range of specialists — dermatologists, pediatric oncologists, pediatricians and radiotherapists, who directly comprehensively treat children with malignant tumors, undergoing radiation therapy, and strive to optimize their treatment tolerability and quality of life.

Authors

Institutions

Publication Details

Journal
Russian Journal of Clinical Dermatology and Venereology
Published
2025-09-10
DOI
https://doi.org/10.17116/klinderma202524041470
Primary Topic
Chemotherapy-related skin toxicity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevention and treatment of dermal toxicity in children receiving anti-tumor radiation

M. S. Neznakhina, Т. Т. Валиев, Н.П. Баранова, С. Р. Варфоломеева et al.
Russian Journal of Clinical Dermatology and Venereology
Chemotherapy-related skin toxicity
article

Prevention and treatment of dermal toxicity in children receiving anti-tumor radiation

M. S. Neznakhina, Т. Т. Валиев, Н.П. Баранова, С. Р. Варфоломеева, Т. С. Белышева, O. M. Romantsova, I.L. Shlivko, V. A. Grigorenko, E. I. Shirikov, К. И. Киргизов, V. G. Polyakov, Л. С. Круглова, M. V. Rubanskaya, E.S. Rannev, E. V. Krivova, N.N. Cheban
article en

Abstract

Radiation therapy, being an integral part of malignant neoplasms treatment in children, is unfortunately inevitably accompanied by a high frequency of adverse dermatological reactions. Development of radiodermatitis — from erythema and dryness to oozing lesion, painfulness and ulcerations — is a considerable clinical problem, significantly deteriorates the quality of life of young patients and creates the risk of infectious complications, that could potentially lead to interruptions in life-saving treatment. Critically important is that currently there are almost no randomized controlled studies in the pediatric population specifically devoted to systematic assessment of profile, severity and optimal management of dermatological toxicity caused by radiation therapy. This article focuses on the urgent need and crucial significance of comprehensive supportive skin therapy during and after radiation. Such care includes regular and targeted use of special dermatoprotective products. Moisturizing creams and ointments are designed to combat dryness, desquamation and maintain the integrity of the hydrolipid barrier. Barrier agents (often based on zinc, silicone or special polymers) create a protective film that minimizes friction, mechanical damage and contact with irritants as well as promote healing. The main objectives of this strategy are effective management of clinical manifestations of acute radiodermatitis, maximum possible prevention and minimization of severe skin lesions, as well as significant acceleration of their recovery and re-epithelization processes in the post-radiation period. The obtained results and collated recommendations are of significant practical interest to a wide range of specialists — dermatologists, pediatric oncologists, pediatricians and radiotherapists, who directly comprehensively treat children with malignant tumors, undergoing radiation therapy, and strive to optimize their treatment tolerability and quality of life.

Russian Journal of Clinical Dermatology and VenereologyVol. 24(4)
Privolzhsky Research Medical University (RU), Sechenov University (RU), Pirogov Russian National Research Medical University (RU), Central State Medical Academy (RU), Russian Medical Academy of Continuous Professional Education (RU), St. Petersburg Institute of Bioregulation and Gerontology (RU), Quadient (United Kingdom) (GB)
Openalex Percentile: Top 57%
Chemotherapy-related skin toxicity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.